HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
4,4'-[2,2,2-Trifluor-1-(trifluormethyl)ethyliden]diphenol
BPAF · BISPHENOL AF · HEXAFLUOROBISPHENOL A · 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol · 2,2-BIS(4-HYDROXYPHENYL)HEXAFLUOROPROPANE · 4,4'-(HEXAFLUOROISOPROPYLIDENE)DIPHENOL · 4,4'-(Perfluoropropane-2,2-diyl)diphenol · BIS-AF
![Molekülstruktur von 4,4'-[2,2,2-Trifluor-1-(trifluormethyl)ethyliden]diphenol](/img/chemical/73864.png)
Identifikatoren & physikalische Daten
| CAS No. | 1478-61-1 |
|---|---|
| Summenformel | C15H10F6O2 |
| Durchschnittliche Molmasse | 336,23 g/mol |
| Monoisotopische Masse | 336,05849888 g/mol |
| SMILES | Oc1ccc(C(c2ccc(O)cc2)(C(F)(F)F)C(F)(F)F)cc1 |
| InChIKey | ZFVMWEVVKGLCIJ-UHFFFAOYSA-N |
| PubChem CID | 73864 |
| ChEMBL | CHEMBL1900054 |
| ChEBI | CHEBI:72754 |
| EC No. | 216-036-7 |
| DTXSID | DTXSID7037717 |
| Lokaler Name | 4,4'-[2,2,2-Trifluor-1-(trifluormethyl)ethyliden]diphenol |
Chemische & physikalische Eigenschaften
| XLogP | 4,5 |
|---|---|
| Polarare Oberfläche (TPSA) | 40,5 |
| H-Brücken-Donoren | 2 |
| H-Brücken-Akzeptoren | 8 |
| Frei drehbare Bindungen | 2 |
| Schwere Atome | 23 |
| Formalladung | 0 |
| Komplexität | 352 |
| Stoffklassen | Bisphenol |
| PFAS | PFAS -> PFAS identified in REACH Regulation EC No. 1272/2008PFAS -> Identified in migrating and extractable food contact chemical dataPFAS -> Intentionally added food contact chemicalsPFAS -> Other/unspecifiedPFAS -> Suspected persistent, mobile, toxic (PMT) PFAS or PFAS-like compounds |
| Dichte | 1.447 gm/cu cm[NTPChemical Information Profile for Bisphenol AF1.3837 (estimate) |
| Color/Form | White to light gray powder |
| Löslichkeit | Solubility in water: NegligibleDMSO (Slightly), Methanol (Slightly)Insoluble in water. |
| Endocrine Disruptors | Potential endocrine disrupting compound |
| Siedepunkt | 400 °C[NTPChemical Information Profile for Bisphenol AF400°C |
| Decomposition | When heated to decomposition it emits toxic vapors of fluorine |
| Schmelzpunkt | 159- 162 °C160-163 °C(lit.) |
| Physical Description | Dry PowderOther Solid |
| Collision Cross Section | 165.6 Ų [M-H]- [CCS Type: DTBuffer gas: N2Ionization: ESI-Dataset: TOXCASTSource Identifier: DTXSID7037717]230.13 Ų [2M-H]- |
| Dampfdruck | 0Pa at 20℃ |
| Flammpunkt | >100°C |
| Lagerbedingungen | Inert atmosphere,Room Temperature |
| pKa (Säurekonstante) | 8.74±0.10(Predicted) |
| Aggregatzustand | powder |
| Farbe | White to Pale Beige |
| BRN | 1891568 |
| Henry-Konstante | 1.7×104 mol/(m3Pa) at 25℃, HSDB (2015) |
| Hauptanwendungen | cleaning productscosmeticsfood and beveragespersonal care |
| InChI | 1S/C15H10F6O2/c16-14(17,18)13(15(19,20)21,9-1-5-11(22)6-2-9)10-3-7-12(23)8-4-10/h1-8,22-23H |
| InChIKey | ZFVMWEVVKGLCIJ-UHFFFAOYSA-N |
| SMILES | Oc1ccc(cc1)C(c2ccc(O)cc2)(C(F)(F)F)C(F)(F)F |
| LogP (Verteilungskoeffizient) | 2.79 at 20℃ |
| CAS Datenbank | 1478-61-1(CAS DataBase Reference) |
| EPA chemische Informationen | Phenol, 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis- (1478-61-1) |
Sicherheit & Vorschriften
| GHS-Einstufung | DangerH360F: May damage fertility [Danger Reproductive toxicity]P203, P280, P318, P405, and P501 (click each P-code to see the statement)H315 (56%): Causes skin irritation [Warning Skin corrosion/irritation]P203, P260, P261, P264, P264+P265, P271, P273, P280, P302+P352, P304+P340, P305+P351+P338, P305+P354+P338, P317, P318, P319, P321, P332+P317, P337+P317, P362+P364, P391, P403+P233, P405, and P501 (click each P-code to see the statement) |
|---|---|
| Regulatorische Informationen | Chemical: Phenol, 4,4â²-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis-Hazard Traits - Endocrine ToxicityReproductive ToxicityPhenol, 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis- is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Phenol, 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis- are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)Status: Active Update: 16-03-2023 https://echa.europa.eu/registration-dossier/-/registered-dossier/23236Substance: 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol (Bisphenol AF)Phenol, 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis-: Does not have an individual approval but may be used under an appropriate group standard |
| Hazard Classes and Categories | Skin Irrit. 2 (56%)Serious eye damage/eye irritation - Category 1Repr. 1B |
| Entsorgungsverfahren | SRP: The most favorable course of action is to use an alternative chemical product with less inherent propensity for occupational harm/injury/toxicity or environmental contamination. Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air qualitypotential migration in soil or watereffects on animal and plant lifeand conformance with environmental and public health regulations. |
| Wechselwirkungen | Exposure to xenoestrogens occurs against a backdrop to physiological levels of endogenous estrogens. Endogenous estrogen levels vary from low levels in early childhood to high levels during pregnancy and in young women. However, few studies have addressed how xenoestrogens interact with endogenous estrogens. The current study was designed to characterize the individual dose-response curves of estradiol-17beta (E(2)), bisphenol A (BPA), tetrabromo-bisphenol A (TBBPA), and bisphenol AF (BPAF, 4,4'-hexafluoroisopropylidene diphenol) on estrogen-dependent luciferase expression in T47D-KBluc cells and to determine how binary (8 x 8 factorial) and ternary (4 x 4 x 4 factorial) mixtures of an endogenous estrogen (E(2)) interact with BPA and/or BPAF. Log EC(50) and hillslope values with SEs, respectively, for individual compounds were as follows: E(2), -12.10M +/- 0.06071, 0.7702 +/- 0.1739 |
Anwendungen & Verwendung
Verwenden
Hexafluorobisphenol A acts as an endocrine-disrupting chemical (EDC), activating estrogen through the estrogen receptor ERα. It is a full agonist for the estrogen receptor.